1,3-dipropyl-8-cyclopentylxanthine has been researched along with Cancer of Kidney in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the role of A1R in renal cell carcinoma (RCC) remains not well-known." | 1.46 | The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma. ( Chu, X; Dai, Y; Deng, F; Tang, J; Tang, Y; Tong, L; Zhou, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Tong, L | 1 |
| Chu, X | 1 |
| Deng, F | 1 |
| Tang, J | 1 |
| Tang, Y | 1 |
| Dai, Y | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Cancer of Kidney
| Article | Year |
|---|---|
The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.
Topics: Adenosine A1 Receptor Antagonists; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferat | 2017 |